PDCD1 and melanoma: It appears that the melanoma intrinsic FTO pathway is not only critical for melanoma malignant traits and tumorigenicity in immunocompromised hosts, but also crucial for promoting resistance to IFNγ-induced killing in vitro and anti-PD-1 blockade in immunocompetent hosts in vivo.